ACLX Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

SPRZEDAż 121861 min ago

@ $63.29

Wydano: 14 vas. 2024 @ 16:30

Zwrot: -17.44%

Poprzedni sygnał: vas. 12 - 20:39

Poprzedni sygnał: Kupno

Zwrot: -0.81 %

Live Chart Being Loaded With Signals

Commentary (8 geg. 2024 @ 23:00):

Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases...

Stats
Dzisiejszy wolumen	354 356
Średni wolumen	451 716
Kapitalizacja rynkowa	2.76B
EPS	$0 ( 2024-04-03 )
Następna data zysków	( $-0.510 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-35.54
ATR14	$0.0610 (0.12%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-01	Heery Christopher	Sell	10 000	Stock Option (right to buy)
2024-05-01	Heery Christopher	Buy	18 168	Common Stock
2024-05-01	Heery Christopher	Sell	7 087	Common Stock
2024-05-01	Heery Christopher	Sell	8 168	Stock Option (right to buy)
2024-05-01	Heery Christopher	Sell	10 481	Common Stock

INSIDER POWER
-46.83
Last 100 transactions
Buy: 1 137 648 \| Sell: 3 745 923

Wolumen Korelacja

Długi: 0.23 (neutral)

Krótki: -0.76 (moderate negative)

Signal:(47.404) Neutral

Arcellx, Inc. Korelacja

10 Najbardziej pozytywne korelacje
RMRM	0.953
MOTNU	0.932
LIAN	0.911
NYMX	0.911
AGYS	0.909
SDIG	0.909
PSCH	0.908
GLMD	0.908
PSCC	0.906
ICON	0.906

10 Najbardziej negatywne korelacje
ATHN	-0.935
NXTC	-0.932
PTRA	-0.932
IOAC	-0.932
LITE	-0.93
GTLB	-0.928
CWBR	-0.924
AXDX	-0.921
TSLA	-0.92
LGHL	-0.917

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Arcellx, Inc. Korelacja - Waluta/Towar

-0.71
( moderate negative )

-0.63
( weak negative )

0.00
( neutral )

-0.62
( weak negative )

0.29
( neutral )

0.34
( neutral )

Arcellx, Inc. Finanse

Annual	2023
Przychody:	$110.32M
Zysk brutto:	$108.28M (98.15 %)
EPS:	$-1.470

FY	2023
Przychody:	$110.32M
Zysk brutto:	$108.28M (98.15 %)
EPS:	$-1.470

FY	2022
Przychody:	$0
Zysk brutto:	$-2.22M (0.00 %)
EPS:	$-4.22

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-6.02

Financial Reports:

No articles found.

Arcellx, Inc.

Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It is also developing ACLX-001, an immunotherapeutic combination composed of ARC-T cells and bi-valent SparX proteins targeting BCMA to treat r/r MM; ACLX-002 and ACLX-003 for treating r/r acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS); and other AML/MDS product candidates, as well as solid tumor programs. The company was formerly known as Encarta Therapeutics, Inc. and changed its name to Arcellx, Inc. in January 2016. Arcellx, Inc. was incorporated in 2014 and is headquartered in Gaithersburg, Maryland.

Aktualne aktualizacje dla Arcellx, Inc. [ACLX]

Upcoming Earnings Alert